Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 23 ... obstructed kidney than sham-operated ones. In contrast, angiotensin-converting enzyme (ACE) protein expression was significantly lower in UUO hamsters. In UUO hamsters, treatment ... Syrian hamsters were subjected to UUO and treated with vehicle, the specific chymase inhibitor (CI) 4-[1-(4-methyl-benzo[b]thiophen-3-ylmethyl)-1H-benzimidazol-2-ylsulfanyl]-butyric ...
2009 NOV 16 ... system." "We examined the effect of a short-term treatment with the ACE inhibitor enalapril in 47 patients with severe coronary artery disease requiring coronary artery ...
2009 OCT 12 ... "Many patients with high blood pressure or heart failure are currently treated with ACE inhibitor drugs. However, some patients do not respond sufficiently to ACE inhibitors alone. We ...
2009 NOV 2 ... for cardiovascular risk reduction in high-risk patients who are unable to take an ACE inhibitor, and the availability of a telmisartan-amlodipine combination for hypertension, give ...
2009 NOV 16 ... analyzed blood pressure and graft survival according to antihypertensive treatment with ACE-I/ARB and/or calcium channel blockers (CCB) over a period of 10 years," scientists in ... "Whether the use of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker inhibitor (ACEI/ARB) is beneficial in renal transplant ...
2009 NOV 2 ... of a heart attack and chronic heart failure. Captopril (sold as Capoten), the first ACE inhibitor to be taken orally, has been commonly available in the United States since the early ...
2009 NOV 2 ... combination therapy without a diuretic. Among included patients 75.7% received also an ACE inhibitor or an angiotensin II receptors blocker, 43.9% a calcium channel blocker, and 32.8% a ...
2009 OCT 5 ... with nephropathy should include treatment with the maximum recommended doses of an ACE inhibitor or ARB in addition to lowering blood pressure to target. For patients with overt ...
2009 OCT 5 ... occur despite the long-term administration of angiotensin converting enzyme-inhibitors (ACE-I) (ie, aldosterone breakthrough). The angiotensin II receptor blocker (ARB) telmisartan ... colleagues published their study in International Heart Journal (Effects of ARB or ACE-Inhibitor Administration on Plasma Levels of Aldosterone and Adiponectin in Hypertension. ...
2009 OCT 5 ... has received much of the attention. The renal outcomes in ONTARGET suggest that combined ACE inhibitor and ARB therapy contributes to a higher rate of adverse renal outcomes than ...
2009 NOV 16 ... "We present the safety and efficacy of an intensified triple RAS blockade with an ACE-inhibitor, an AT 1 receptor blocker and the direct renin inhibitor aliskiren in a ...
2009 NOV 2 ... to a study from Cape Town, South Africa, "Human somatic angiotensin-converting enzyme (ACE) is a membrane-bound dipeptidyl carboxypeptidase that contains two extracellular domains ... domain residues were used to scrutinize the contribution of these residues to selective inhibitor binding. Enzyme kinetic analyses of the purified mutants indicated that the RXPA380 ...
2009 OCT 19 ... data suggest an advantage of perindopril over other ACEIs at the level of tissue ACE inhibition and relative selectivity for bradykinin, which may explain the mechanism of ... "In EUROPA, the angiotensin-converting enzyme inhibitor (ACEI) perindopril on top of other preventative therapies reduced the risk of major ...
2009 OCT 5 ... fashion by an internal medicine adjudication committee and expert reviewer. Concurrent ACE inhibitor or angiotensin receptor blocker exposure was ascertained from case report forms. drug ...
2009 OCT 5 ... reticulum stress and apoptosis in experimental diabetic nephropathy. The effects of ACE inhibitor on the endoplasmic reticulum stress and apoptosis were also assessed." ...
2009 NOV 23 ... of Hypertension (Dual Blockade of the Renin-Angiotensin-Aldosterone System: Beyond the ACE Inhibitor and Angiotensin-II Receptor Blocker Combination. American Journal of Hypertension, ...
2009 OCT 5 ... Suppression of the renin angiotensin system using angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blocker (ARB) drug therapies has been shown to ... cardiovascular agent, VTP-27999. VTP-27999 is a novel, proprietary renin inhibitor discovered and advanced by Vitae. "Renin inhibition offers a powerful approach to blood ...
2009 NOV 23 ... Suppression of the renin angiotensin system using angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blocker (ARB) drug therapies has been shown to ... discovery and development company, announced the company's novel, clinical-stage renin inhibitor, VTP-27999, has been recognized by Windhover as a "Top 10 Project to Watch" in the ...
